A Monotherapy in Subjects With Advanced Solid Tumors
Clinical trial NCT04221204 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04221204
- Sponsor
- 3D Medicines (Beijing) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2026-12-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.